HLSHealiusHLS info
$0.87info-0.72%24h
Global rank10478
Market cap$538.61M
Change 7d-2.83%
YTD Performance-15.90%
SP500 benchmarkUnderperform
P/E-1.46
P/S0.50
Revenue$1.09B
Earnings-$234.03M
Dividend yield-
Main Sector
Healthcare

Healius (HLS) Stock Overview

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

HLS Stock Information

Symbol
HLS
Address
Liberty PlaceSydney, NSW 2000Australia
Founded
-
Trading hours
10:00 AM - 4:00 PM AEST
Website
https://www.healius.com.au
Country
🇦🇺 Australia
Phone Number
61 2 9432 9400

Healius (HLS) Price Chart

-
Value:-

Healius Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.8749101228691961
N/A
Market Cap
$538.61M
N/A
Shares Outstanding
615.61M
-2.35%
Employees
10.50K
N/A
Shareholder Equity
1.51B
-21.62%
Valuation
2023
Change
P/E Ratio
-1.46
N/A
P/S Ratio
0.50
N/A
P/B Ratio
0.36
N/A
Growth
2023
Change
Return on Equity
-0.1554
N/A
Earnings
2023
Change
Revenue
$1.09B
N/A
Earnings
-$234.03M
N/A
EPS
-0.5975
N/A
Earnings Yield
-0.6829
N/A
Gross Margin
0.8689
N/A
Operating Margin
0.0575
N/A
Net income margin
-0.2155
N/A
Financial Strength
2023
Change
Total Assets
$2.32B
N/A
Total Debt
$1.12B
N/A
Cash on Hand
$73.37M
N/A
Debt to Equity
0.9070
23.65%
Cash to Debt
0.0653
42.86%
Current Ratio
0.5469
-5.68%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org